Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus

Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus

IntroductionThe combination of everolimus (EVR) and low-dose tacrolimus (lowTAC) prevents T cell-mediated rejection of liver grafts as sufficiently as high-dose tacrolimus (highTAC) and mycophenolate, but is associated with a preserved kidney function within the first years after orthotopic liver tr...

Full description

Bibliographic Details
Main Authors: Emily A. Bosselmann, Fabian Dranicki, Alejandro Campos-Murguia, Björn Hartleben, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Transplantation
Subjects:
graft injury
fibrosis
mTOR inhibitor
everolimus
immunosuppression
tacrolimus
Online Access:https://www.frontiersin.org/articles/10.3389/frtra.2023.1168163/full

Internet

https://www.frontiersin.org/articles/10.3389/frtra.2023.1168163/full

Similar Items